Skip to main content
SinoMab BioScience Limited logo

SinoMab BioScience Limited — Investor Relations & Filings

Ticker · 3681 ISIN · HK0000544194 LEI · 9845009B6CEEC4694006 HKEX Manufacturing
Open in API
Filings indexed 319 across all filing types
Latest filing 2025-04-24 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 3681

About SinoMab BioScience Limited

http://www.sinomab.com

SinoMab BioScience Limited is a clinical-stage biopharmaceutical company specializing in the research, development, and commercialization of therapeutic antibodies. The company focuses on developing novel, highly efficacious drugs, including "first-in-class" and "best-in-class" candidates, primarily for the treatment of immunological and life-threatening diseases, such as rheumatoid arthritis. SinoMab maintains full-spectrum drug development capabilities, covering antibody re-engineering, bioprocessing, and manufacturing, aimed at addressing significant unmet medical needs globally.

Recent filings

Filing Released Lang Actions
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD AT ROOM 3, 14/F, FAIRMONT HOUSE, 8 COTTON TREE DRIVE, CENTRAL, HONG KONG ON FRIDAY, 13 JUNE 2025 AT 10:00 A.M.
Proxy Solicitation & Information Statement Classification · 95% confidence The document is clearly a form of proxy for the upcoming Annual General Meeting, providing voting instructions and soliciting proxies. This fits the definition of Proxy Solicitation & Information Statement (PSI) rather than an AGM presentation (AGM-R) or voting results (DVA).
2025-04-24 English
PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a shareholder circular for SinoMab BioScience Limited’s 2025 Annual General Meeting, including a notice of AGM, proposals for re-electing directors, share buy-back and issuance mandates, and instructions for proxy voting. It is not the full annual report, earnings release, or regulatory notice, but rather materials sent to shareholders to request votes at the meeting. This aligns with the definition of a Proxy Solicitation & Information Statement (PSI).
2025-04-24 English
Annual Report 2024
Regulatory Filings
2025-04-24 English
INSIDE INFORMATION POSITIVE TOPLINE RESULTS FROM PHASE 1B CLINICAL TRIAL OF SM17 IN CHINA FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS
Regulatory Filings Classification · 95% confidence The document is a Hong Kong Stock Exchange announcement disclosing inside information – positive topline results from a Phase 1b clinical trial for SM17. It is not a financial report (10-K, IR, ER), not a management or governance statement, nor a capital or share transaction notice. It does not request shareholder votes or detail dividends, M&A, or board changes. It is a routine regulatory disclosure of R&D progress under the Listing Rules. Therefore, it falls under the general “Regulatory Filings” category (RNS).
2025-04-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
Regulatory Filings Classification · 95% confidence The document is an FF301 monthly return filed to the Hong Kong Exchange detailing movements in issued and treasury shares, share options, and confirmations under Listing Rule Chapter 19B. It is a routine regulatory compliance return rather than a full financial report, management discussion, or transaction announcement. This falls under general regulatory filings (fallback category).
2025-04-03 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024&#x3b; AND CHANGE IN USE OF PROCEEDS
Earnings Release Classification · 95% confidence The document is a Hong Kong Exchanges announcement titled "Annual Results Announcement for the year ended 31 December 2024". It provides audited consolidated annual results and key financial and business highlights, but does not include the full annual report. This corresponds to an Earnings Release (initial announcement of periodical financial results). FY 2024
2025-03-31 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.